| |
Department of Medicine
- Staff
Associate Professor Bridget A Robinson
BMedSc MD(Otago) FRACP
Oncology Service
Christchurch Hospital
Private Bag 4710
Christchurch
New Zealand
Email: bridget.robinson@cdhb.govt.nz |
 |
Current Roles
- Medical Oncologist, Christchurch Hospital
- Co-convenor professional development thread, 4th and 5th year medicine
- Chair of Canterbury Cancer Network, linking scientists and clinicians
managing cancer
Research Interests
- Co-director Angiogenesis Research Group
- Clinical collaborator, Cancer Genetics Research Group
- Director: Cancer Society Tissue Bank
- Clinical trials for cancer patients
Top 10 Publications
- Gunningham, S., Currie, M., Cheng, H., Scott, P., Robinson B., Harris,
A., Fox, S. VEGF-B expression in human breast cancers is associated
with positive lymph node status. J Pathol 193: 325 – 32 (2001).
- Currie, M., Hanrahan, V., Gunningham, S., Morrin, H., Framptom, C.,
Han., Robinson, B., Fox,S. Expression of Vascular Endothelial Growth
Factor-D is associated with Hypoxia Inducible Factor (HIF-1a) and the
HIF-1a target gene DEC1, but not lymph node metastasis in primary human
breast carcinomas. J Clin Pathol 2004;57,829-834.
- Currie, M., Gunningham, S., Han, C., Scott, P., Robinson, B., Harris,
A., Fox, S. Angiopoietin-1 is inversely related to thymidine phosphorylase
expression in human breast cancer, indicating a role in vascular remodeling.
Clinical Cancer Research 7 (4): 918 – 27 (2001).
- Gunningham, S., Currie, M., Han, C., Turner, K., Scott, P., Robinson, B., Harris, A., Fox, S. Vascular endothelial growth factor-B and vascular
endothelial growth factor-C expression in renal cell carcinomas: regulation
by the von Hippel-Lindau gene and hypoxia. Cancer Research 61 (7):
3206 – 11 (2001).
- Morrin, H., Gunningham, S., Currie, M., Dachs, G., Fox, S., Robinson, B. The Christchurch Tissue bank to support cancer research. NZ Med
J 2005;118, 1225:1735.
- Currie, M., Gunningham, S., Turner, K., Han, C., Scott, P., Robinson B., Chong, W., Harris, AL., Fox, S.B.. Expression of the angiopoietins
and their receptor Tie2 in human renal clear cell carcinomas; regulation
by the von Hippel-Lindau gene and hypoxia. Journal of Pathology. 198:
502 – 510 (2002).
- Hanrahan, V., Gunningham, S., Currie, M., Morrin, H., Scott, P.,
Robinson B., Fox, S.B.. The angiogenic switch for vascular endothelial
growth factor (VEGF) –A, VEGF-B, VEGF-C, VEGF-D in the adenoma – carcinoma
sequence during colorectal cancer progression. Journal of Pathology
200: 183-194 (2003).
- Roberts, R., Gearry, R., Allington, M., Morrin, H., Robinson, B.,
Frizelle, F. Caspase Recruitment Domain-Containing Protein 15 mutations
in patients with colorectal cancer. Cancer Research 2006; 66:2532-2535.
- Dachs, G., Steele, A., Coralli, C., Kanthou, C., Brooks, A., Gunningham,
S., Currie, M., Watson, A., Robinson, B., Tozer, G. Anti-vascular agent
Combretastatin A-4-P modulates Hypoxia Inducible factor-1 and gene
expression. BMC Cancer 2006; 6:280.
- Harvey, V., Mouridsen, H., Semiglazov, V., Jakobsen, E., Voznyi,
E., Robinson, B., Groult, V., Murawsky, M., Cold, S. Phase III trial
comparing three doses of docetaxel for second-line treatment of advanced
breast cancer. J Clin Oncol, 2006; 24:4963-70.
Department of Medicine Publications
Back to Top
Return to Staff Page
|
|
